Hengrui Pharmaceuticals Gains NMPA Clearance for Phase II Study of HRS-7058 in Solid Tumors
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has announced clearance from the National Medical...
Pfizer Halts Development of Danuglipron Due to Drug-Induced Liver Injury Case
US pharmaceutical giant Pfizer Inc. (NYSE: PFE) has announced the termination of development for its...
Roche’s Columvi Approved by EC for Relapsed DLBCL Treatment in Europe
Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) has announced that it has received marketing...
Hengrui Pharmaceuticals Gains NMPA Approval for SHR-1819 in Allergic Rhinitis Study
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has announced that it has received approval...
CSPC Pharmaceutical Gains FDA Approval for SYS6041 ADC in Advanced Solid Tumors
China-based CSPC Pharmaceutical Group Co., Ltd. (HKG: 1093) has announced that it has received clinical...
Boehringer Ingelheim Partners with Cue Biopharma to Advance CUE-501 for Autoimmune Diseases
Germany’s Boehringer Ingelheim (BI) has entered into a strategic agreement with US-based Cue Biopharma, Inc....
Peijia Medical’s TaurusTrio TAV System Accepted for NMPA Review in China
China-based Peijia Medical Ltd (HKG: 9996) has announced that the National Medical Products Administration (NMPA)...
HighTide Therapeutics’ HTD1801 Shows Positive Phase III Results in Type 2 Diabetes Treatment
China-based HighTide Therapeutics Inc. (HKG: 2511) has announced positive results from two Phase III clinical...
Zhuhai Beihai Biotech Gains NMPA Clinical Clearance for Innovative Peptide-Drug Conjugate BH259
China-based Zhuhai Beihai Biotech Co., Ltd. has announced that it has received clinical trial clearance...
Novlead Biotech Secures Series C Financing to Expand NO Inhalation Therapy Device Production
Novlead Biotech, a Nanjing-based specialist in nitric oxide (NO) gas detection and treatment, has secured...
Chromatin Bioscience Collaborates with Astellas Pharma to Design Cell-Selective Synthetic Promoters
UK-headquartered Chromatin Bioscience has entered into a collaboration with Japan-based Astellas Pharma Inc. (TYO: 4503)...
MSD’s Gardasil 9 Approved in China for Males Aged 16 to 26
US pharmaceutical major Merck, Sharp & Dohme (MSD; NYSE: MRK) has announced marketing approval from...
NHC Urges Hospitals to Establish Healthy Weight Management Clinics by June
The National Health Commission (NHC) has issued a notification encouraging eligible Class 3 general hospitals,...
Mabwell and DP Technology Collaborate to Build Biopharma AI Platform for Drug Development
Chinese companies Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) and DP Technology have entered into...
Bristol-Myers Squibb Wins FDA Approval for Opdivo-Yervoy Combo in First-Line HCC Treatment
Bristol-Myers Squibb (BMS, NYSE: BMY) has secured another indication approval from the US Food and...
Jiangxi Institute of Biological Products Files for Hong Kong IPO Amid Strong Market Position
Jiangxi Institute of Biological Products Inc., China’s largest provider and exporter of human tetanus antitoxin...
Zhaoke Ophthalmology Launches Phase II Study for Brimochol PF in Presbyopia Treatment
Zhaoke Ophthalmology Ltd (HKG: 6622) has announced the initiation of a multi-center, double-blinded, crossover, placebo-controlled...
CSPC Pharmaceutical Gains NMPA Approval for Clinical Trial of SYH2046 in Heart Failure
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced that it has received approval from...
Amgen’s Imdelltra Shows Positive Phase III Results in Small Cell Lung Cancer
US biotech giant Amgen (NASDAQ: AMGN) has announced positive results from the global Phase III...
Shanghai Microport EP Medtech Secures NMPA Fast-Track Designation for EasyEcho Catheter
China’s Shanghai Microport EP Medtech Co., Ltd (SHA: 688351) has announced that it has received...